Literature DB >> 6128572

Cortical muscarinic receptor subtypes and Alzheimer's disease.

M P Caulfield, D W Straughan, A J Cross, T Crow, N J Birdsall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128572     DOI： 10.1016/s0140-6736(82)90129-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

3.  Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

Authors:  J J Claus; E A Dubois; J Booij; J Habraken; J C de Munck; M van Herk; B Verbeeten; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-06

4.  Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?

Authors:  L Nilsson; A Adem; J Hardy; B Winblad; A Nordberg
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

5.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study.

Authors:  T Sunderland; G Esposito; S E Molchan; R Coppola; D W Jones; J Gorey; J T Little; M Bahro; D R Weinberger
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

7.  Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.

Authors:  A Nordberg; P Nyberg; R Adolfsson; B Winblad
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.

Authors:  Elizabeth Scarr; Catriona McLean; Brian Dean
Journal:  J Neural Transm (Vienna)       Date:  2016-09-29       Impact factor: 3.575

9.  Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

Authors:  D J Wyper; D Brown; J Patterson; J Owens; R Hunter; E Teasdale; J McCulloch
Journal:  Eur J Nucl Med       Date:  1993-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.